Characterization of ganglionic acetylcholine receptor autoantibodies

Journal of Neuroimmunology

Volumn 197, Issue 1, 2008, Pages 63-69

  Vernino, Steven ^a   Lindstrom, Jon ^b   Hopkins, Steve ^a   Wang, Zhengbei ^a   Low, Phillip A ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Mayo Clinic College of Medicine   (United States)

Author keywords

Autonomic; Bungarotoxin; Epibatidine; Myasthenia; Neuronal; Subunits

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE AUTONOMIC GANGLIONOPATHY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOREACTIVITY; MOUSE; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; CELL LINE; CELL LINE, TUMOR; GANGLIA, AUTONOMIC; HUMANS; MICE; MICE, NUDE; MUSCLE, SKELETAL; RABBITS; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC;

EID: 44649202073     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.03.017     Document Type: Article

References (29)

1. Drachman D. Myasthenia gravis. N. Engl. J. Med. 330 (1994) 1797-1810
2. Feng G., Steinbach J.H., and Sanes J.R. Rapsyn clusters neuronal acetylcholine receptors but is inessential for formation of an interneuronal cholinergic synapse. J. Neurosci. 18 (1998) 4166-4176
3. Gibbons C.H., Vernino S.A., and Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch. Neurol. 65 (2008) 213-217
4. Klein C.M., Vernino S., Lennon V.A., Sandroni P., Fealey R.D., Benrud-Larson L., Sletten D., and Low P.A. The spectrum of autoimmune autonomic neuropathies. Ann. Neurol. 53 (2003) 752-758
5. Kostelidou K., Trakas N., and Tzartos S.J. Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency. J. Neuroimmunol. 190 (2007) 44-52
6. Kuryatov A., Luo J., Cooper J., and Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol. Pharmacol. 68 (2005) 1839-1851
7. Lennon V.A., Ermilov L.G., Szurszewski J.H., and Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest. 111 (2003) 907-913
8. Lindstrom J., Luo J., and Kuryatov A. MG and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains. Ann. N. Y. Acad. Sci. 1132 (2008)
9. Muscle Study Group, in press. A Trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology. doi:10.1212/01.wnl.0000312373.67493.7f.
10. Nelson M.E., Wang F., Kuryatov A., Choi C.H., Gerzanich V., and Lindstrom J. Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells. J. Gen. Physiol. 118 (2001) 563-582
11. Ragheb S., Mohamed M., and Lisak R.P. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor. J. Neuroimmunol. 159 (2005) 137-145
12. Schroeder C., Vernino S., Birkenfeld A.L., Tank J., Heusser K., Lipp A., Benter T., Lindschau C., Kettritz R., Luft F.C., and Jordan J. Plasma exchange for primary autoimmune autonomic failure. N. Engl. J. Med. 353 (2005) 1585-1590
13. Sideris S., Lagoumintzis G., Kordas G., Kostelidou K., Sotiriadis A., Poulas K., and Tzartos S.J. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture. J. Neuroimmunol. 189 (2007) 111-117
14. Skok M.V., Voitenko L.P., Voitenko S.V., Lykhmus E.Y., Kalashnik E.N., Litvin T.I., Tzartos S.J., and Skok V.I. Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha(181-192) peptide antibodies. Neuroscience 93 (1999) 1427-1436
15. Tzartos S.J., and Lindstrom J.M. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 755-759
16. Tzartos S.J., Barkas T., Cung M.T., Mamalaki A., Marraud M., Orlewski P., Papanastasiou D., Sakarellos C., Sakarellos-Daitsiotis M., Tsantili P., and Tsikaris V. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163 (1998) 89-120
17. Vernino S. Experimental acetylcholine receptor autoimmunity: coexisting myasthenia and autonomic failure. Neuromuscul. Disord. 16 supp 1 (2006) S180
18. Vernino S., and Lennon V.A. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 26 (2002) 702-707
19. Vernino S., Adamski J., Kryzer T.J., Fealey R.D., and Lennon V.A. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50 (1998) 1806-1813
20. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., and Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343 (2000) 847-855
21. Vernino S., Cheshire W.P., and Lennon V.A. Myasthenia gravis with autoimmune autonomic neuropathy. Auton. Neurosci. 88 (2001) 187-192
22. Vernino S., Kryzer T., and Lennon V. Autoantibodies in Autoimmune Autonomic Neuropathies and Neuromuscular Hyperexcitability Disorders. In: Rose N., Hamilton R., and Detrick B. (Eds). Manual of Clinical Laboratory Immunology. 6th ed. (2002), ASM Press, Washington, D.C 1013-1017
23. Vernino S., Low P.A., and Lennon V.A. Experimental autoimmune autonomic neuropathy. J. Neurophysiol. 90 (2003) 2053-2059
24. Vernino S., Ermilov L.G., Sha L., Szurszewski J.H., Low P.A., and Lennon V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 24 (2004) 7037-7042
25. Wang F., Nelson M.E., Kuryatov A., Olale F., Cooper J., Keyser K., and Lindstrom J. Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells. J. Biol. Chem. 273 (1998) 28721-28732
26. Wang Z., Low P.A., Jordan J., Freeman R., Gibbons C.H., Schroeder C., Sandroni P., and Vernino S. Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology 68 (2007) 1917-1921
27. Watson R., Jepson J.E., Bermudez I., Alexander S., Hart Y., Mcknight K., Roubertie A., Fecto F., Valmier J., Sattelle D.B., Beeson D., Vincent A., and Lang B. Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 65 (2005) 1802-1804
28. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., and Beaudet A.L. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5746-5751
29. Xu W., Orr-Urtreger A., Nigro F., Gelber S., Sutcliffe C.B., Armstrong D., Patrick J.W., Role L.W., Beaudet A.L., and De Biasi M. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci. 19 (1999) 9298-9305